All Type of News
“Medical association must stop making excuses with the Valsartan case”
As the Korean Medical Association uses the Valsartan case as a reason to oppose to introduction of the international proprietary names, the Korean Pharmaceutical Association criticized that the medical association was...
“Narcotic drugs cannot be advertised in pamphlets and brochures”
Unlike other ETC drugs, narcotics must be attentively handled because anyone who uses media such as pamphlets and brochures to advertise narcotics might be imposed criminal punishment and administrative measures.
The...
Health and Welfare Committee will be managed by Liberty Korea Part for second half of the 20th National Assembly
While the opposing and ruling parties concluded a negotiation on parliamentary committees, a party was selected for the Health and Welfare Committee.
Young-Pyo Hong at The Minjoo Party, Sung-Tae Kim at Liberty Korea ...
Pharma industry highly concerns about conflicts between medical and pharmaceutical associations over ‘Valsartan’
The pharmaceutical industry has shown high interests in recruiting the chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA).
In the circumstance where the antihypertensive ‘Valsartan’ ...
‘Lacked qualification & frequent quit’ cause manpower insufficiency in biopharmaceutical field
Compared to the increase of demands for human resources in the biopharmaceutical field, companies are experiencing relative difficulties in recruiting employees in the actual field.
Life-Based Project Center Director...
Most companies used Chinese Valsartan ingredients were small and medium-sized
As it was indicated that the active pharmaceutical ingredient ‘Valsartan’ manufactured by Zhejiang Huahai will likely to be used, sales suspension of 91 out of 219 antihypertensive products has been cleared off. The r...
115 products with temporary sales and manufacturing suspension while 104 were cancelled
The number of antihypertensive products containing Chinese ‘Valsartan’ ingredients cancelled in sales suspension was increased from 92 products in the morning to 104 products.
On the 9th, the Ministry of Food and Dru...
Health insurance benefits on 125 products containing Huahai’s Valsartan temporarily suspended
The health insurance benefits for 125 antihypertensive products which use Chinse ‘Valsartan’ have been suspended.
The Ministry of Health and Welfare(MOHW) Pharmaceutical Benefits Division informed the ‘Notification A...
Sales suspension of 91 products not using Chinese ‘Valsartan’ cancelled
The sales suspension on the 91 antihypertensives that was confirmed not to use Chinese ‘Valsartan’ will be cancelled.
The Ministry of Food and Drug Safety(Minister Young-Jin Ryu) inspected 187 of 219 antihypertensive...
What patients, hospitals and pharmacies should do about antihypertensives containing Chinese Valsartan?
While sales and health insurance benefits of the antihypertensives containing ‘Valsartan’ manufactured by Chinese Zhejiang Huahai have been suspended, the government recommended to take an action of giving a guidance ...
